Non-cytotoxic functions of lymphoycte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
基本信息
- 批准号:7070841
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Upon antigen recognition, effector T lymphocytes secrete a variety of mediators that influence, creating a network of responsive cells. Most of these mediators are newly synthesized proteins that are immediately exported from the T cells. However, cytotoxic lymphocytes have a hallmark "regulated" secretory pathway in which pre-formed cytotoxic mediators (perforin and granzymes) are stored in cytoplasmic granules until antigen signaling triggers their rapid exocytosis. Another laboratory studying cloned cytotoxic T cells reported that the chemokine RANTES was also stored in cytotoxic granules. When we examined activation-induced RANTES secretion from purified memory and effector subpopulations of CD8+ human T cells from blood as well as short term cultured blasts, we found an early burst of preformed RANTES secretion with more rapid kinetics than the exocytosis of the lysosomal/cytotoxic granules. Deconvolution fluorescence microscopy revealed that intracellular RANTES is present in vesicles that do not colocalize with lysosomal markers, perforin or granzymes, a result confirmed by immunogold staining of ultrathin EM sections. Like these CD8+ lymphocytes, CD4+ blasts and NK cells also contain preformed RANTES in highly mobilizable non-lysosomal cytoplasmic vesicles, providing a rapid burst of local chemokine release that can recruit other inflammatory cells after antigen recognition. As a follow-up project, we have examined the intracellular localization and surface expression of the negative regulator CTLA-4 in T cell blasts and in the CD4+CD25+ "T regulatory" cells. This protein binds avidly to co-stimulatory molecules on antigen-presenting cells and negatively signals T cells, allowing for a termination of antigen-induced activation. In both types of T cells, deconvolution microscopy shows that CTLA-4 is present in vesicles that do not significantly colocalize with lysosomal or endosomal markers. In mouse lymph node CD4+CD25+ cells, activation-induced CTLA-4 surface expression is rapid, and resistant to protein synthesis inhibitors for the first hour. Using Rab27a-defective ashen mice that fail to exocytose lysosomal/cytotoxic granules after TcR crosslinking, this stimulation triggers normal CTLA-4 surface expression in both CD8+ T cell blasts and in the CD4+CD25+ "T regulatory" cells. The Rab27a-independent exocytosis of CTLA-4 indicates that intracellular CTLA-4 in T cells is stored in yet another distinct T cell compartment that undergoes rapid TcR-induced exocytosis.
在抗原识别后,效应T淋巴细胞分泌多种影响的介质,产生应答细胞的网络。这些介质中的大多数是新合成的蛋白质,它们立即从T细胞输出。然而,细胞毒性淋巴细胞具有标志性的“调节”分泌途径,其中预先形成的细胞毒性介质(穿孔素和颗粒酶)储存在细胞质颗粒中,直到抗原信号传导触发它们的快速胞吐作用。另一个研究克隆细胞毒性T细胞的实验室报告说,趋化因子RANTES也储存在细胞毒性颗粒中。当我们检查激活诱导的RANTES分泌从纯化的记忆和效应器亚群的CD 8+人T细胞从血液以及短期培养的母细胞,我们发现了一个更快的动力学比溶酶体/细胞毒性颗粒的胞吐作用的预先形成的RANTES分泌的早期爆发。去卷积荧光显微镜显示,细胞内RANTES存在于囊泡中,不与溶酶体标志物,穿孔素或颗粒酶共定位,结果证实了免疫金染色的ESPREEM切片。与这些CD 8+淋巴细胞一样,CD 4+母细胞和NK细胞也在高度可动员的非溶酶体胞质囊泡中含有预先形成的RANTES,提供了局部趋化因子释放的快速爆发,可以在抗原识别后招募其他炎性细胞。作为一个后续项目,我们已经检查了细胞内的定位和表面表达的负调节CTLA-4在T细胞母细胞和在CD 4 + CD 25+“T调节”细胞。这种蛋白质与抗原呈递细胞上的共刺激分子结合,并向T细胞发出负信号,从而终止抗原诱导的活化。在两种类型的T细胞中,去卷积显微镜显示CTLA-4存在于不与溶酶体或内体标记物显著共定位的囊泡中。在小鼠淋巴结CD 4 + CD 25+细胞中,活化诱导的CTLA-4表面表达是快速的,并且在第一个小时内对蛋白质合成抑制剂具有抗性。使用在TcR交联后不能胞吐溶酶体/细胞毒性颗粒的Rab 27 a缺陷型灰白色小鼠,这种刺激触发了CD 8 + T细胞母细胞和CD 4 + CD 25+“T调节”细胞中的正常CTLA-4表面表达。CTLA-4的Rab 27 a非依赖性胞吐表明T细胞中的细胞内CTLA-4储存在经历快速TcR诱导的胞吐的另一个不同的T细胞区室中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pierre A Henkart其他文献
Pierre A Henkart的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pierre A Henkart', 18)}}的其他基金
Non-cytotoxic functions of lymphocyte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
- 批准号:
6948361 - 财政年份:
- 资助金额:
-- - 项目类别:
Non-cytotoxic functions of lymphoycte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
- 批准号:
7292106 - 财政年份:
- 资助金额:
-- - 项目类别:
Non-cytotoxic functions of lymphoycte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
- 批准号:
6758411 - 财政年份:
- 资助金额:
-- - 项目类别:
Non-cytotoxic functions of lymphoycte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
- 批准号:
6557495 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
-- - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
-- - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Studentship